Dr. David Ternant, PharmD, Ph.D. is a Senior Researcher at the University of Tours. He has international expertise in target-mediated pharmacokinetics (TMDD) and concentration-effect relationships of therapeutic monoclonal antibodies in humans. He is also a hospital practitioner in the pharmacology-toxicology department of the University Hospital of Tours, France, where He specialized in TDM of several therapeutic areas.